Cargando…
Low-dose rituximab should be used for treating MS in resource-limited settings: No
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131394/ https://www.ncbi.nlm.nih.gov/pubmed/35437067 http://dx.doi.org/10.1177/13524585221089889 |
| _version_ | 1784713165462831104 |
|---|---|
| author | Mateen, Farrah J |
| author_facet | Mateen, Farrah J |
| author_sort | Mateen, Farrah J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9131394 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91313942022-05-26 Low-dose rituximab should be used for treating MS in resource-limited settings: No Mateen, Farrah J Mult Scler Controversies in Multiple Sclerosis SAGE Publications 2022-04-18 2022-06 /pmc/articles/PMC9131394/ /pubmed/35437067 http://dx.doi.org/10.1177/13524585221089889 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Controversies in Multiple Sclerosis Mateen, Farrah J Low-dose rituximab should be used for treating MS in resource-limited settings: No |
| title | Low-dose rituximab should be used for treating MS in resource-limited
settings: No |
| title_full | Low-dose rituximab should be used for treating MS in resource-limited
settings: No |
| title_fullStr | Low-dose rituximab should be used for treating MS in resource-limited
settings: No |
| title_full_unstemmed | Low-dose rituximab should be used for treating MS in resource-limited
settings: No |
| title_short | Low-dose rituximab should be used for treating MS in resource-limited
settings: No |
| title_sort | low-dose rituximab should be used for treating ms in resource-limited
settings: no |
| topic | Controversies in Multiple Sclerosis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131394/ https://www.ncbi.nlm.nih.gov/pubmed/35437067 http://dx.doi.org/10.1177/13524585221089889 |
| work_keys_str_mv | AT mateenfarrahj lowdoserituximabshouldbeusedfortreatingmsinresourcelimitedsettingsno |